Overall, our results show that the switch of monocytes to the inflammatory subset and IFN-I signaling activation by PTBP2-overexpressing NB cells, which were responsible for the tumor-inhibiting effect, was independent of the CCL5/CCR5 axis. The gene discussed is CCR5; the disease is neuroblastoma.